International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Desmopressin 4-mcg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Page(s): 64

Download in electronic PDF format for $75

Abstract: A formulation for preparing Desmopressin 4-mcg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, desmopressin acetate, synthetic octapeptide hormone, vasopressin analog, diabetes insipidus, bleeding, hemophilia A, primary nocturnal enuresis, von Willebrand disease type I

Related Categories: DIABETES, FORMULATIONS, PARENTERALS, STERILE PREPARATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Desmopressin 4-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 64
Five Compounds for Treating Diabetes-Related Conditions Meece Jerry	May/Jun 2003 Pg. 170-174
Stability of Diluted Desmopressin Acetate Intranasal Solution at 0.01 mg/mL Friciu Mihaela, Bharadwaj Priyanshu, Bertrand Laurence, Roy-St-Pierre Émilie, Forest Jean-Marc, Leclair Grégoire	Nov/Dec 2024 Pg. 509-514
Desmopressin Acetate Nasal Solution 0.033 mg/mL Allen Loyd V Jr	May/Jun 2000 Pg. 167
Vasopressin 20-units/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 69
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Octreotide 50-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 72
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Complications of Diabetes Key David M	Mar/Apr 2000 Pg. 88-90
Chromium 4-mcg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 157
Diabetes Book Reviews Reed-Kane Dana	Mar/Apr 2000 Pg. 103-104
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2002 Pg. 44
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections Allen Loyd V Jr	Jan/Feb 2012 Pg. 73
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Allen Loyd V Jr	Jan/Feb 2012 Pg. 75
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R	Jul/Aug 2011 Pg. 290-300
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 161
Return to Top